Skip to main content

Advertisement

SpringerLink
Log in

Hypophosphatemia in critically ill patients with acute kidney injury on renal replacement therapies

  • Review
  • Published:
Journal of Nephrology Aims and scope Submit manuscript

Abstract

Hypophosphatemia is a common but often underestimated electrolyte derangement among intensive care unit (ICU) patients. Low phosphate levels can lead to cellular dysfunction with potentially relevant clinical manifestations (e.g., muscle weakness, respiratory failure, lethargy, confusion, arrhythmias). In critically ill patients with severe acute kidney injury (AKI) renal replacement therapies (RRTs) represent a well-known risk factor for hypophosphatemia, especially if the most intensive and prolonged modalities of RRT, such as continuous RRT or prolonged intermittent RRT, are used. Currently, no evidence-based specific guidelines are available for the treatment of hypophosphatemia in the critically ill; however, considering the potentially negative impact of hypophosphatemia on morbidity and mortality, strategies aimed at reducing its incidence and severity should be timely implemented in the ICUs. In the clinical setting of critically ill patients on RRT, the most appropriate strategy could be to anticipate the onset of RRT-related hypophosphatemia by implementing the use of phosphate-containing solutions for RRT through specifically designed protocols. The present review is aimed at summarizing the most relevant evidence concerning epidemiology, prognostic impact, prevention and treatment of hypophosphatemia in critically ill patients with AKI on RRT, with a specific focus on RRT-induced hypophosphatemia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Suzuki S, Egi M, Schneider AG, Bellomo R, Hart GK, Hegarty C (2013) Hypophosphatemia in critically ill patients. J Crit Care 28:536

    PubMed  Google Scholar 

  2. Ronco C, Ricci Z, De Backer D, Kellum JA, Taccone FS, Joannidis M, Pickkers P, Cantaluppi V, Turani F, Saudan P, Bellomo R, Joannes-Boyau O, Antonelli M, Payen D, Prowle JR, Vincent JL (2015) Renal replacement therapy in acute kidney injury: controversy and consensus. Crit Care 19:146

    PubMed  PubMed Central  Google Scholar 

  3. Bugg NC, Jones JA (1998) Hypophosphataemia. Pathophysiology, effects and management on the intensive care unit. Anaesthesia 53:895–902

    CAS  PubMed  Google Scholar 

  4. Kim SY, Kim YN, Shin HS, Jung Y, Rim H (2017) The influence of hypophosphatemia on outcomes of low- and high-intensity continuous renal replacement therapy in critically ill patients with acute kidney injury. Kidney Res Clin Pract 36:240–249

    PubMed  PubMed Central  Google Scholar 

  5. Geerse DA, Bindels AJ, Kuiper MA, Roos AN, Spronk PE, Schultz MJ (2010) Treatment of hypophosphatemia in the intensive care unit: a review. Crit Care 14:R147

    PubMed  PubMed Central  Google Scholar 

  6. Troyanov S, Geadah D, Ghannoum M, Cardinal J, Leblanc M (2004) Phosphate addition to hemodiafiltration solutions during continuous renal replacement therapy. Intensive Care Med 30:1662–1665

    PubMed  Google Scholar 

  7. VA/NIH Acute Renal Failure Trial Network, Palevsky PM, Zhang JH, O’Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM, Smith MW, Swanson KM, Thompson BT, Vijayan A, Watnick S, Star RA, Peduzzi P (2008) Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 359:7–20

    Google Scholar 

  8. RENAL Replacement Therapy Study Investigators, Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S, McArthur C, McGuinness S, Myburgh J, Norton R, Scheinkestel C, Su S (2009) Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 361:1627–1638

    Google Scholar 

  9. Santiago MJ, López-Herce J, Urbano J, Bellón JM, del Castillo J, Carrillo A (2009) Hypophosphatemia and phosphate supplementation during continuous renal replacement therapy in children. Kidney Int 75:312–316

    CAS  PubMed  Google Scholar 

  10. Demirjian S, Teo BW, Guzman JA, Heyka RJ, Paganini EP, Fissell WH, Schold JD, Schreiber MJ (2011) Hypophosphatemia during continuous hemodialysis is associated with prolonged respiratory failure in patients with acute kidney injury. Nephrol Dial Transplant 26:3508–3514

    CAS  PubMed  Google Scholar 

  11. Broman M, Carlsson O, Friberg H, Wieslander A, Godaly G (2011) Phosphate-containing dialysis solution prevents hypophosphatemia during continuous renal replacement therapy. Acta Anaesthesiol Scand 55:39–45

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Maynar Moliner J, Honore PM, Sánchez-Izquierdo Riera JA, Herrera Gutiérrez M, Spapen HD (2012) Handling continuous renal replacement therapy-related adverse effects in intensive care unit patients: the dialytrauma concept. Blood Purif 34:177–185

    CAS  PubMed  Google Scholar 

  13. Yang Y, Zhang P, Cui Y, Lang X, Yuan J, Jiang H, Lei W, Lv R, Zhu Y, Lai E, Chen J (2013) Hypophosphatemia during continuous veno-venous hemofiltration is associated with mortality in critically ill patients with acute kidney injury. Crit Care 17:R205

    PubMed  PubMed Central  Google Scholar 

  14. Park JT, Lee H, Kee YK, Park S, Oh HJ, Han SH, Joo KW, Lim CS, Kim YS, Kang SW, Yoo TH, Kim DK, HICORES Investigators (2016) High-dose versus conventional-dose continuous venovenous hemodiafiltration and patient and kidney survival and cytokine removal in sepsis-associated acute kidney injury: a randomized controlled trial. Am J Kidney Dis 68:599–608

    PubMed  Google Scholar 

  15. Lim C, Tan HK, Kaushik M (2017) Hypophosphatemia in critically ill patients with acute kidney injury treated with hemodialysis is associated with adverse events. Clin Kidney J 10:341–347

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Talakoub R, Bahrami M, Honarmand A, Abbasi S, Gerami H (2017) The predicting ability of serum phosphorus to assess the duration of mechanical ventilation in critically ill patients. Adv Biomed Res 6:51

    PubMed  PubMed Central  Google Scholar 

  17. Bech A, Blans M, Raaijmakers M, Mulkens C, Telting D, de Boer H (2013) Hypophosphatemia on the intensive care unit: individualized phosphate replacement based on serum levels and distribution volume. J Crit Care 28:838–843

    CAS  PubMed  Google Scholar 

  18. Agarwal B, Walecka A, Shaw S, Davenport A (2014) Is parenteral phosphate replacement in the intensive care unit safe? Ther Apher Dial 18:31–36

    CAS  PubMed  Google Scholar 

  19. Chua HR, Baldwin I, Ho L, Collins A, Allsep H, Bellomo R (2012) Biochemical effects of phosphate-containing replacement fluid for continuous venovenous hemofiltration. Blood Purif 34:306–312

    CAS  PubMed  Google Scholar 

  20. Chua HR, Schneider AG, Baldwin I, Collins A, Ho L, Bellomo R (2013) Phoxilium vs hemosol-B0 for continuous renal replacement therapy in acute kidney injury. J Crit Care 28:884.e7–884.e14

    CAS  Google Scholar 

  21. Morabito S, Pistolesi V, Tritapepe L, Zeppilli L, Polistena F, Fiaccadori E, Pierucci A (2013) Regional citrate anticoagulation in CVVH: a new protocol combining citrate solution with a phosphate-containing replacement fluid. Hemodial Int 17:313–320

    PubMed  Google Scholar 

  22. Morabito S, Pistolesi V, Tritapepe L, Vitaliano E, Zeppilli L, Polistena F, Fiaccadori E, Pierucci A (2013) Continuous veno-venous hemofiltration using a phosphate-containing replacement fluid in the setting of regional citrate anticoagulation. Int J Artif Organs 36:845–852

    PubMed  Google Scholar 

  23. Morabito S, Pistolesi V, Tritapepe L, Vitaliano E, Zeppilli L, Polistena F, Fiaccadori E, Pierucci A (2013) Continuous venovenous hemodiafiltration with a low citrate dose regional anticoagulation protocol and a phosphate-containing solution: effects on acid-base status and phosphate supplementation needs. BMC Nephrol 14:232

    PubMed  PubMed Central  Google Scholar 

  24. Godaly G, Carlsson O, Broman M (2016) Phoxilium(®) reduces hypophosphataemia and magnesium supplementation during continuous renal replacement therapy. Clin Kidney J 9:205–210

    CAS  PubMed  Google Scholar 

  25. Pistolesi V, Zeppilli L, Polistena F, Sacco MI, Pierucci A, Tritapepe L, Regolisti G, Fiaccadori E, Morabito S (2017) Preventing continuous renal replacement therapy-induced hypophosphatemia: an extended clinical experience with a phosphate-containing solution in the setting of regional citrate anticoagulation. Blood Purif 44:8–15

    CAS  PubMed  Google Scholar 

  26. Fiaccadori E, Coffrini E, Ronda N, Vezzani A, Cacciani G, Fracchia C, Rampulla C, Borghetti A (1990) Hypophosphatemia in course of chronic obstructive pulmonary disease. Prevalence, mechanisms, and relationships with skeletal muscle phosphorus content. Chest 97:857–868

    CAS  PubMed  Google Scholar 

  27. Fiaccadori E, Coffrini E, Fracchia C, Rampulla C, Montagna T, Borghetti A (1994) Hypophosphatemia and phosphorus depletion in respiratory and peripheral muscles of patients with respiratory failure due to COPD. Chest 105:1392–1398

    CAS  PubMed  Google Scholar 

  28. Jung SY, Kim H, Park S, Jhee JH, Yun HR, Kim H, Kee YK, Yoon CY, Oh HJ, Chang TI, Park JT, Yoo TH, Kang SW, Lee H, Kim DK, Han SH (2016) Electrolyte and mineral disturbances in septic acute kidney injury patients undergoing continuous renal replacement therapy. Medicine (Baltimore) 95:e4542

    CAS  Google Scholar 

  29. Thongprayoon C, Cheungpasitporn W, Mao MA, Sakhuja A, Erickson SB (2018) Admission hyperphosphatemia increases the risk of acute kidney injury in hospitalized patients. J Nephrol 31:241–247

    CAS  PubMed  Google Scholar 

  30. Barak V, Schwartz A, Kalickman I, Nisman B, Gurman G, Shoenfeld Y (1998) Prevalence of hypophosphatemia in sepsis and infection: the role of cytokines. Am J Med 104:40–47

    CAS  PubMed  Google Scholar 

  31. Berger MM, Rothen C, Cavadini C, Chiolero RL (1997) Exudative mineral losses after serious burns: a clue to the alterations of magnesium and phosphate metabolism. Am J Clin Nutr 65:1473–1481

    CAS  PubMed  Google Scholar 

  32. Polderman KH, Bloemers FW, Peerdeman SM, Girbes AR (2000) Hypomagnesemia and hypophosphatemia at admission in patients with severe head injury. Crit Care Med 28:2022–2025

    CAS  PubMed  Google Scholar 

  33. Buell JF, Berger AC, Plotkin JS, Kuo PC, Johnson LB (1998) The clinical implications of hypophosphatemia following major hepatic resection or cryosurgery. Arch Surg 133:757–761

    CAS  PubMed  Google Scholar 

  34. Cohen J, Kogan A, Sahar G, Lev S, Vidne B, Singer P (2004) Hypophosphatemia following open heart surgery: incidence and consequences. Eur J Cardiothorac Surg 26:306–310

    PubMed  Google Scholar 

  35. Salem RR, Tray K (2005) Hepatic resection-related hypophosphatemia is of renal origin as manifested by isolated hyperphosphaturia. Ann Surg 241:343–348

    PubMed  PubMed Central  Google Scholar 

  36. Morimatsu H, Uchino S, Bellomo R, Ronco C (2002) Continuous veno-venous hemodiafiltration or hemofiltration: impact on calcium, phosphate and magnesium concentrations. Int J Artif Organs 25:512–519

    CAS  PubMed  Google Scholar 

  37. Song YH, Seo EH, Yoo YS, Jo YI (2019) Phosphate supplementation for hypophosphatemia during continuous renal replacement therapy in adults. Ren Fail 41:72–79

    CAS  PubMed  PubMed Central  Google Scholar 

  38. Sun Z, Ye H, Shen X, Chao H, Wu X, Yang J (2014) Continuous venovenous hemofiltration versus extended daily hemofiltration in patients with septic acute kidney injury: a retrospective cohort study. Crit Care 18:R70

    PubMed  PubMed Central  Google Scholar 

  39. Albino BB, Balbi AL, Abrão JM, Ponce D (2015) Dialysis complications in acute kidney injury patients treated with prolonged intermittent renal replacement therapy sessions lasting 10 versus 6 hours: results of a randomized clinical trial. Artif Organs 39:423–431

    CAS  PubMed  Google Scholar 

  40. Terlevich A, Hearing SD, Woltersdorf WW, Smyth C, Reid D, McCullagh E, Day A, Probert CS (2003) Refeeding syndrome: effective and safe treatment with phosphates polyfusor. Aliment Pharmacol Ther 17:1325–1329

    CAS  PubMed  Google Scholar 

  41. Chanchal R, Gupta S, Kanta C, Singh K, Koonwar S (2018) Hypophosphataemia in severe acute malnutrition: a prospective observational study. Br J Nutr 17:1–6

    Google Scholar 

  42. Bollaert PE, Levy B, Nace L, Laterre PF, Larcan A (1995) Hemodynamic and metabolic effects of rapid correction of hypophosphatemia in patients with septic shock. Chest 107:1698–1701

    CAS  PubMed  Google Scholar 

  43. Sykes L, Nipah R, Kalra P, Green D (2018) A narrative review of the impact of interventions in acute kidney injury. J Nephrol 31:523–535

    PubMed  Google Scholar 

  44. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group (2012) KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl S2:1–138

    Google Scholar 

  45. Pistolesi V, Di Napoli A, Fiaccadori E, Zeppilli L, Polistena F, Sacco MI, Regolisti G, Tritapepe L, Pierucci A, Morabito S (2016) Severe acute kidney injury following cardiac surgery: short-term outcomes in patients undergoing continuous renal replacement therapy (CRRT). J Nephrol 29:229–239

    PubMed  Google Scholar 

  46. Ratanarat R, Brendolan A, Volker G, Bonello M, Salvatori G, Andrikos E, Yavuz A, Crepaldi C, Ronco C (2005) Phosphate kinetics during different dialysis modalities. Blood Purif 23:83–90

    CAS  PubMed  Google Scholar 

  47. Schwartz A, Brotfain E, Koyfman L, Kutz R, Gruenbaum SE, Klein M, Zlotnik A (2014) Association between hypophosphatemia and cardiac arrhythmias in the early stage of sepsis: could phosphorus replacement treatment reduce the incidence of arrhythmias? Electrolyte Blood Press 12:19–25

    CAS  PubMed  PubMed Central  Google Scholar 

  48. Ariyoshi N, Nogi M, Ando A, Watanabe H, Umekawa S (2017) Cardiovascular consequences of hypophosphatemia. Panminerva Med 59:230–240

    PubMed  Google Scholar 

  49. Chanutin A, Hermann E (1969) The interaction of organic and inorganic phosphates with hemoglobin. Arch Biochem Biophys 131:180–184

    CAS  PubMed  Google Scholar 

  50. Lichtman MA, Miller DR, Cohen J, Waterhouse C (1971) Reduced red cell glycolysis, 2, 3-diphosphoglycerate and adenosine triphosphate concentration, and increased hemoglobin-oxygen affinity caused by hypophosphatemia. Ann Intern Med 74:562–568

    CAS  PubMed  Google Scholar 

  51. Sharma S, Brugnara C, Betensky RA, Waikar SS (2015) Reductions in red blood cell 2,3 diphosphoglycerate concentration during continuous renal replacement therapy. Clin J Am Soc Nephrol 10:74–79

    CAS  PubMed  Google Scholar 

  52. Rosen GH, Boullata JI, O’Rangers EA, Enow NB, Shin B (1995) Intravenous phosphate repletion regimen for critically ill patients with moderate hypophosphatemia. Crit Care Med 23:1204–1210

    CAS  PubMed  Google Scholar 

  53. Shajahan A, Ajith Kumar J, Gireesh Kumar KP, Sreekrishnan TP, Jismy K (2015) Managing hypophosphatemia in critically ill patients: a report on an under-diagnosed electrolyte anomaly. J Clin Pharm Ther 40:353–354

    CAS  PubMed  Google Scholar 

  54. Engwerda E, Van den Berg M, Blans M, Bech A, De Boer H (2018) Efficacy and safety of a phosphate replacement strategy for severe hypophosphatemia in the ICU. Neth J Med 76:437–441

    CAS  PubMed  Google Scholar 

  55. Chow MT, Lin HJ, Mitra EA, Singh S, Lee E, Leehey DJ, Ing TS (1998) Hemodialysis-induced hypophosphatemia in a normophosphatemic patient dialyzed for ethylene glycol poisoning: treatment with phosphorus-enriched hemodialysis. Artif Organs 22:905–907

    CAS  PubMed  Google Scholar 

  56. Dorval M, Pichette V, Cardinal J, Geadah D, Ouimet D, Leblanc M (1999) The use of an ethanol- and phosphate-enriched dialysate to maintain stable serum ethanol levels during haemodialysis for methanol intoxication. Nephrol Dial Transplant 14:1774–1777

    CAS  PubMed  Google Scholar 

  57. Santiago MJ, López-Herce J, Muñoz R, del Castillo J, Urbano J, Solana MJ, Botrán M (2011) Stability of continuous renal replacement therapy solutions after phosphate addition: an experimental study. Ther Apher Dial 15:75–80

    PubMed  Google Scholar 

  58. Heung M, Mueller BA (2018) Prevention of hypophosphatemia during continuous renal replacement therapy—an overlooked problem. Semin Dial 31:213–218

    PubMed  Google Scholar 

  59. Shaw AR, Chaijamorn W, Clark JS, Mueller BA (2018) Preparation times and costs for various solutions used for continuous renal replacement therapy. Am J Health Syst Pharm 75:808–815

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. UO Dialisi, Azienda Ospedaliero-Universitaria Policlinico Umberto I, “Sapienza” Università di Roma, Viale del Policlinico, 155, 00161, Rome, Italy

    Valentina Pistolesi, Laura Zeppilli & Santo Morabito

  2. UOC Nefrologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy

    Laura Zeppilli

  3. Università Cattolica del Sacro Cuore, Rome, Italy

    Laura Zeppilli

  4. UO Nefrologia, Azienda Ospedaliero-Universitaria Parma, Dipartimento di Medicina e Chirurgia, Università di Parma, Parma, Italy

    Enrico Fiaccadori & Giuseppe Regolisti

  5. UO Anestesia e Terapia Intensiva in Cardiochirurgia, Azienda Ospedaliero-Universitaria Policlinico Umberto I, “Sapienza” Università di Roma, Rome, Italy

    Luigi Tritapepe

Authors
  1. Valentina Pistolesi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laura Zeppilli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Enrico Fiaccadori
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Giuseppe Regolisti
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Luigi Tritapepe
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Santo Morabito
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

VP, LZ and SM had the idea for the review, performed the literature search and data analysis, and drafted the work. EF, GR and LT critically revised the work.

Corresponding author

Correspondence to Valentina Pistolesi.

Ethics declarations

Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Ethical approval

This article does not contain any studies with human participants performed by any of the authors.

Informed consent

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pistolesi, V., Zeppilli, L., Fiaccadori, E. et al. Hypophosphatemia in critically ill patients with acute kidney injury on renal replacement therapies. J Nephrol 32, 895–908 (2019). https://doi.org/10.1007/s40620-019-00648-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40620-019-00648-5

Keywords

Search

Navigation